Abstract
Presentation Description :
The past year has witnessed investments in artificial intelligence in areas that span medical science and healthcare, including for the detection and monitoring of disorders that manifest in the eye. In this talk, I will explore the potential of AI for improving screening and detection, and for gaining mechanistic insight into glaucoma and other diseases of the eye. I will also identify situations under which the current tools of AI might be unsuitable, suggest alternative approaches for such cases, and also highlight how future developments of AI might ultimately provide new tools for hypothesis-driven research.
This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.